Logo

Genomics: Clinical Implementation

This channel includes news headlines and educational resources regarding the clinical implementation of genomics assays, including development, validation, quality control, standardization, and the practical and commercial considerations for labs adopting these tests. 

Aug 18, 2022

Cancer Centers Nudge Oncologists Toward DPYD Testing as PGx Supporters Push For Guidelines Change
Premium

Aug 8, 2022

CAP Weighs in on dMMR, MSI Assays for Immunotherapy Patient Selection
Premium

Aug 8, 2022

Small Cell Lung Cancer Detection, Classification Achieved Using Cell-Free DNA Methylation

Aug 3, 2022

Exact Sciences Partners With West German Study Group to Validate MRD Test in Breast Cancer

Aug 2, 2022

Guardant Health Receives Medicare Coverage for MRD Liquid Biopsy in Stage II and III Colon Cancer

Jul 29, 2022

Stakeholders Urge Collaboration to Prove ctDNA as Regulatory Endpoint for Early Cancer Drugs
Premium

Jul 28, 2022

Adaptive Biotech's ClonoSeq Gets Expanded Medicare Coverage For B-Cell Lymphoma

Jul 22, 2022

Lung Cancer MRD Study Bolsters Validity Evidence, Suggests Longitudinal Test Cutoff
Premium

Jul 12, 2022

NCCN Publishes First Guidelines for Pediatric Brain Cancer, Recommends Broad NGS Profiling

Jul 8, 2022

BillionToOne, UCSD Partner to Assess New Liquid Biopsy Assays in Lung Cancer

Jul 7, 2022

ESMO Releases Guidelines for Liquid Biopsy Testing in Cancer Patients

Jun 30, 2022

CMS Retains Unspecified Cancer Dx Codes After Industry Stakeholder Feedback
Premium

Jun 30, 2022

Analysis of Tumor Mutation, Treatment Data Across Cancers Points to Predictive Biomarkers

Jun 29, 2022

Sarcoma Patients Should Receive Genomic Profiling More Often, Research Suggests
Premium

Jun 24, 2022

Molecular Tumor Profiling Benefits Pediatric Cancer Patients, Study Finds

Jun 22, 2022

Agendia Building Validation Data on ImPrint for Guiding Neoadjuvant Immunotherapy in Breast Cancer
Premium

Jun 8, 2022

New Data Suggests Liquid Biopsy Provides Early ID of Breast Cancer Patients Destined to Recur
Premium

Jun 7, 2022

Circulating Tumor DNA Utility in Post-Surgery Stage II Colon Cancer Cemented by New Data
Premium

May 20, 2022

MSK Starts Offering Pediatric Cancer Patients Whole-Genome, Transcriptome Sequencing
Premium

May 18, 2022

Illumina, Allegheny Health Network Collaborate on Study of Cancer Genomic Profiling